3B BlackBio Dx Ltd manufactures and exports PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents, and agrochemical-based productsBusiness Segments A) Diagnostics Business (81% of FY23 revenue) 3BDL is part of an Indo-Spanish JV and was formed by amalgamation with its parent company Kilpest India Limited. Company is an...
3B BlackBio Dx Limited reported consolidated Q1 revenue of ₹22.23 Cr and profit after tax of ₹12.64 Cr. The company has acquired 100% stake in CorisHolding SRL, Belgium, a rapid diagnostic solutions manufacturer, for £2.765 Million. This strategic move aims to strengthen its position in the IVD segment and combat...
3B BlackBio Dx Limited has announced an earning conference call for investors and analysts on Tuesday, August 19, 2025, at 5:30 PM (IST). The purpose of this call is to discuss the company's operational and financial performance for the quarter ended June 30, 2025. This call offers a key opportunity...
3B BlackBio Dx Ltd. and its subsidiary TRUPCR® Europe Limited have acquired 100% of Coris Holding SRL for an upfront cash consideration of £0.215 Cr, with potential earn-outs up to £0.0615 Cr, totaling up to £0.2765 Cr. Coris, an In Vitro Diagnostics (IVD) manufacturer specializing in rapid test kits for...
The company has informed its shareholders about a special window opening for re-lodging requests to transfer physical shares. This initiative aims to assist members who hold shares in physical form by providing a dedicated period to process their transfer requests. The announcement was made through social media and newspaper advertisements,...
The company has announced the passing of Mr. Rajesh Dubey, an Independent Director, on July 13. He served on the Board since September 2024, contributing valuable knowledge and experience. His demise represents an irreparable loss to the company. As a result, he is no longer a member of the Nomination...
